AIM
EDIT icon

ARK Investment Management’s Editas Medicine EDIT Stock Holding History

ARK Investment Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-17
Closed -$151 – 224
2022
Q4 		$151 Sell
17
-145,275
-100% -$1.59M ﹤0.01% 231
2022
Q3 		$1.78M Sell
145,292
-108,034
-43% -$1.68M 0.01% 201
2022
Q2 		$2.88M Sell
253,326
-543,915
-68% -$7.29M 0.02% 167
2022
Q1 		$15.2M Sell
797,241
-3,421,061
-81% -$63.6M 0.06% 118
2021
Q4 		$112M Sell
4,218,302
-2,079,057
-33% -$71.6M 0.34% 52
2021
Q3 		$259M Sell
6,297,359
-882,696
-12% -$48.4M 0.62% 41
2021
Q2 		$407M Sell
7,180,055
-1,571,868
-18% -$58.1M 0.76% 35
2021
Q1 		$368M Sell
8,751,923
-1,373,641
-14% -$78.3M 0.73% 43
2020
Q4 		$710M Sell
10,125,564
-544,860
-5% -$22.4M 1.89% 12
2020
Q3 		$299M Buy
10,670,424
+3,124,278
+41% +$102M 1.78% 15
2020
Q2 		$223M Buy
7,546,146
+2,210,205
+41% +$57.8M 2.4% 12
2020
Q1 		$106M Buy
5,335,941
+888,664
+20% +$22.4M 2.64% 13
2019
Q4 		$132M Sell
4,447,277
-485,121
-10% -$12.1M 3.32% 7
2019
Q3 		$112M Buy
4,932,398
+84,250
+2% +$2.09M 2.45% 15
2019
Q2 		$120M Buy
4,848,148
+288,714
+6% +$6.89M 3.02% 10
2019
Q1 		$111M Buy
4,559,434
+1,534,945
+51% +$34.7M 3.19% 10
2018
Q4 		$68.8M Buy
3,024,489
+230,635
+8% +$6.28M 2.79% 13
2018
Q3 		$88.9M Buy
2,793,854
+612,282
+28% +$19.8M 2.69% 11
2018
Q2 		$78.2M Buy
2,181,572
+561,364
+35% +$19.9M 2.86% 11
2018
Q1 		$53.7M Buy
1,620,208
+507,363
+46% +$18.1M 2.67% 11
2017
Q4 		$34.2M Buy
1,112,845
+424,975
+62% +$10.7M 2.72% 8
2017
Q3 		$16.5M Buy
687,870
+177,683
+35% +$3.38M 2.02% 15
2017
Q2 		$8.56M Buy
510,187
+280,265
+122% +$5.05M 1.67% 25
2017
Q1 		$5.13M Buy
+229,922
New +$4.76M 1.48% 27

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

ARK Investment Management's EDIT Position: Q1 2023 in Review

ARK Investment Management sold out of Editas Medicine (EDIT) in Q1 2023, closing a stake of 17 shares — an estimated $151 sold.

ARK Investment Management first reported a position in EDIT in Q1 2017 and held it in 24 quarters. The position peaked at $710M in Q4 2020. 234 funds tracked by Wall St. Rank hold EDIT as of Q1 2023.

  • ARK Investment Management reported no remaining Editas Medicine position as of Q1 2023 after selling out during the quarter.
  • ARK Investment Management sold 17 Editas Medicine shares in Q1 2023, an estimated $151.
  • ARK Investment Management first reported a position in Editas Medicine in Q1 2017 and held it in 24 quarters.
  • ARK Investment Management's Editas Medicine position peaked at $710M in Q4 2020.
  • 234 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2023.

Based on ARK Investment Management's 13F filing for Q1 2023, filed 17 Apr 2023.